Results 21 to 30 of about 15,007 (187)

Anticandidal and Antibiofilm Effect of Synbiotics including Probiotics and Inulin-Type Fructans

open access: yes, 2022
Background: There is great interest in the search for new alternatives to antimicrobial drugs, and the use of synbiotics is a promising approach to this problem. This study evaluated the growth inhibition and antibiofilm activity of the short-chain fatty
Misael S. Gradilla-Hernández   +13 more
core   +1 more source

Antibiofilm and Antimicrobial Properties of 1-allyl-3-(2-diisopropylaminoethyl) Benzimidazolium Chloride and its Silver(I)-NHC Complex

open access: yesCumhuriyet Science Journal, 2022
Today, the number of antimicrobials used in treatment has decreased, especially due to drug resistance. We need new antimicrobials. Biofilms are an important cause of antimicrobial resistance.
Cem Çelik, Uğur Tutar
doaj   +1 more source

Real-Time Assessment of Staphylococcus aureus Biofilm Disruption by Phage-Derived Proteins

open access: yesFrontiers in Microbiology, 2017
A current focus of research is the development of new tools for removing bacterial biofilms in industrial settings. Bacteriophage-encoded proteins, such as endolysins, virion-associated peptidoglycan hydrolases, and exopolysaccharide depolymerases, have ...
Diana Gutiérrez   +5 more
doaj   +1 more source

The Antimicrobial Peptide AMP-17 Derived from Musca domestica Inhibits Biofilm Formation and Eradicates Mature Biofilm in Candida albicans

open access: yes, 2022
The biofilm formation of C. albicans represents a major virulence factor during candidiasis. Biofilm-mediated drug resistance has necessitated the search for a new antifungal treatment strategy.
Chaoqin Sun   +17 more
core   +1 more source

Synergistic Potentiation of Antimicrobial and Antibiofilm Activities of Penicillin and Bacitracin by Octyl Gallate, a Food-Grade Antioxidant, in Staphylococcus epidermidis

open access: yes, 2022
Staphylococcus epidermidis is a major nosocomial pathogen that frequently forms biofilms on indwelling medical devices. This study aimed to investigate the synergistic antimicrobial and antibiofilm activities of octyl gallate (OG) in combination with ...
Ji, Yinduo   +7 more
core   +1 more source

Antibiofilm Effect of Biogenic Silver Nanoparticles Combined with Oregano Derivatives against Carbapenem-Resistant Klebsiella pneumoniae

open access: yesAntibiotics, 2023
Resistant bacteria may kill more people than COVID-19, so the development of new antibacterials is essential, especially against microbial biofilms that are reservoirs of resistant cells.
Sara Scandorieiro   +7 more
doaj   +1 more source

Antibiofilm Activity of Tapak Kuda Ipomoea pes-caprae against Pseudomonas aeruginosa ATCC 27853 and Methicillin-Resistant Staphylococcus aureus (MRSA) ATCC 43300: In-Vitro and In-Silico Evaluation [PDF]

open access: yes, 2023
Ipomoea pes-caprae is one of the herbal plants that can treat various health problems such as skin infections, burns, boils, and various diseases caused by microbial infections. This study aims to identify ethanol extract compounds of I.
Dirayah Rauf Husain   +4 more
core   +1 more source

Complex Networks Analyses of Antibiofilm Peptides: An Emerging Tool for Next-Generation Antimicrobials’ Discovery

open access: yesAntibiotics, 2023
Microbial biofilms cause several environmental and industrial issues, even affecting human health. Although they have long represented a threat due to their resistance to antibiotics, there are currently no approved antibiofilm agents for clinical ...
Guillermin Agüero-Chapin   +8 more
doaj   +1 more source

Natural antibiofilm agents and the need for antibiofilm drug leads [PDF]

open access: yes, 2017
Plant with medicinal property contains different types of bioactive compounds and these compounds are effective against certain diseases. Biofilm infection is a disease caused by biofilm which is associated with the respiratory and gastrointestinal ...
Tucker, Nicholas P.   +2 more
core   +4 more sources

rotaxanes Designed as Pseudomonas aeruginosa Antibiofilm Agents

open access: yes, 2021
Pseudomonas aeruginosa (P.A.) is a human pathogen belonging to the top priorities for the discovery of new therapeutic solutions. Its propensity to generate biofilms strongly complicates the treatments required to cure P.A. infections.
Maude Fransolet (122692)   +19 more
core   +1 more source

Home - About - Disclaimer - Privacy